Logo image of BN.CA

BROOKFIELD CORP (BN.CA) Stock Fundamental Analysis

Canada - TSX:BN - CA11271J1075 - Common Stock

63.31 CAD
0 (0%)
Last: 10/21/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, BN scores 3 out of 10 in our fundamental rating. BN was compared to 76 industry peers in the Capital Markets industry. While BN is still in line with the averages on profitability rating, there are concerns on its financial health. BN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
BN had a positive operating cash flow in the past year.
BN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years BN had a positive operating cash flow.
BN.CA Yearly Net Income VS EBIT VS OCF VS FCFBN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B

1.2 Ratios

BN has a worse Return On Assets (0.13%) than 69.74% of its industry peers.
BN has a Return On Equity of 1.45%. This is in the lower half of the industry: BN underperforms 68.42% of its industry peers.
BN has a Return On Invested Capital (3.69%) which is in line with its industry peers.
BN had an Average Return On Invested Capital over the past 3 years of 3.69%. This is significantly below the industry average of 10.25%.
The 3 year average ROIC (3.69%) for BN is below the current ROIC(3.69%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.13%
ROE 1.45%
ROIC 3.69%
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
BN.CA Yearly ROA, ROE, ROICBN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 0.89%, BN is not doing good in the industry: 67.11% of the companies in the same industry are doing better.
BN's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 26.65%, BN perfoms like the industry average, outperforming 43.42% of the companies in the same industry.
In the last couple of years the Operating Margin of BN has grown nicely.
BN's Gross Margin of 37.81% is on the low side compared to the rest of the industry. BN is outperformed by 61.84% of its industry peers.
BN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 26.65%
PM (TTM) 0.89%
GM 37.81%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
BN.CA Yearly Profit, Operating, Gross MarginsBN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

1

2. Health

2.1 Basic Checks

BN has less shares outstanding than it did 1 year ago.
BN has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for BN is higher compared to a year ago.
BN.CA Yearly Shares OutstandingBN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
BN.CA Yearly Total Debt VS Total AssetsBN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

BN has an Altman-Z score of 0.38. This is a bad value and indicates that BN is not financially healthy and even has some risk of bankruptcy.
BN has a Altman-Z score of 0.38. This is comparable to the rest of the industry: BN outperforms 48.68% of its industry peers.
BN has a Debt/Equity ratio of 4.50. This is a high value indicating a heavy dependency on external financing.
BN's Debt to Equity ratio of 4.50 is on the low side compared to the rest of the industry. BN is outperformed by 93.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.5
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACCN/A
BN.CA Yearly LT Debt VS Equity VS FCFBN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B

2.3 Liquidity

BN has a Current Ratio of 0.56. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.56, BN is not doing good in the industry: 82.89% of the companies in the same industry are doing better.
BN has a Quick Ratio of 0.56. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BN (0.47) is worse than 82.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.47
BN.CA Yearly Current Assets VS Current LiabilitesBN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

5

3. Growth

3.1 Past

BN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.03%.
Measured over the past years, BN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.12% on average per year.
The Revenue for BN has decreased by -19.85% in the past year. This is quite bad
The Revenue has been growing slightly by 4.86% on average over the past years.
EPS 1Y (TTM)-16.03%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%-56.54%
Revenue 1Y (TTM)-19.85%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-21.55%

3.2 Future

BN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.41% yearly.
The Revenue is expected to grow by 27.86% on average over the next years. This is a very strong growth
EPS Next Y-1.97%
EPS Next 2Y8.29%
EPS Next 3Y12.41%
EPS Next 5YN/A
Revenue Next Year28.52%
Revenue Next 2Y35.57%
Revenue Next 3Y27.86%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BN.CA Yearly Revenue VS EstimatesBN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B
BN.CA Yearly EPS VS EstimatesBN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

BN is valuated correctly with a Price/Earnings ratio of 14.59.
Compared to the rest of the industry, the Price/Earnings ratio of BN indicates a slightly more expensive valuation: BN is more expensive than 60.53% of the companies listed in the same industry.
BN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
BN is valuated reasonably with a Price/Forward Earnings ratio of 9.68.
BN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BN is cheaper than 67.11% of the companies in the same industry.
BN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.23.
Industry RankSector Rank
PE 14.59
Fwd PE 9.68
BN.CA Price Earnings VS Forward Price EarningsBN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BN is valued a bit cheaper than the industry average as 60.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.58
BN.CA Per share dataBN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

A more expensive valuation may be justified as BN's earnings are expected to grow with 12.41% in the coming years.
PEG (NY)N/A
PEG (5Y)0.81
EPS Next 2Y8.29%
EPS Next 3Y12.41%

5

5. Dividend

5.1 Amount

BN has a Yearly Dividend Yield of 6.23%, which is a nice return.
BN's Dividend Yield is rather good when compared to the industry average which is at 5.47. BN pays more dividend than 88.16% of the companies in the same industry.
BN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.23%

5.2 History

The dividend of BN decreases each year by -3.57%.
BN has been paying a dividend for at least 10 years, so it has a reliable track record.
BN has decreased its dividend recently.
Dividend Growth(5Y)-3.57%
Div Incr Years1
Div Non Decr Years1
BN.CA Yearly Dividends per shareBN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

102.07% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
DP102.07%
EPS Next 2Y8.29%
EPS Next 3Y12.41%
BN.CA Yearly Income VS Free CF VS DividendBN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5B -10B
BN.CA Dividend Payout.BN.CA Dividend Payout, showing the Payout Ratio.BN.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

TSX:BN (10/21/2025, 7:00:00 PM)

63.31

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners56.37%
Inst Owner ChangeN/A
Ins Owners10.26%
Ins Owner ChangeN/A
Market Cap156.62B
Revenue(TTM)76.08B
Net Income(TTM)675.00M
Analysts76.84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.23%
Yearly Dividend0.61
Dividend Growth(5Y)-3.57%
DP102.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date09-12 2025-09-12 (0.09)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.92%
Min EPS beat(2)-2.36%
Max EPS beat(2)6.19%
EPS beat(4)2
Avg EPS beat(4)3.82%
Min EPS beat(4)-2.36%
Max EPS beat(4)11.75%
EPS beat(8)6
Avg EPS beat(8)12.81%
EPS beat(12)9
Avg EPS beat(12)-0.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1127.6%
Min Revenue beat(2)1118.53%
Max Revenue beat(2)1136.66%
Revenue beat(4)4
Avg Revenue beat(4)1262.07%
Min Revenue beat(4)1118.53%
Max Revenue beat(4)1473.07%
Revenue beat(8)8
Avg Revenue beat(8)846.78%
Revenue beat(12)12
Avg Revenue beat(12)582.41%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.92%
PT rev (3m)11.62%
EPS NQ rev (1m)-37.74%
EPS NQ rev (3m)-38.28%
EPS NY rev (1m)0.22%
EPS NY rev (3m)-1.71%
Revenue NQ rev (1m)7.14%
Revenue NQ rev (3m)7.14%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 14.59
Fwd PE 9.68
P/S 1.47
P/FCF N/A
P/OCF 11.03
P/B 2.39
P/tB N/A
EV/EBITDA 11.58
EPS(TTM)4.34
EY6.86%
EPS(NY)6.54
Fwd EY10.33%
FCF(TTM)-6.19
FCFYN/A
OCF(TTM)5.74
OCFY9.06%
SpS43.19
BVpS26.45
TBVpS-18.17
PEG (NY)N/A
PEG (5Y)0.81
Graham Number50.82
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 1.45%
ROCE 4.96%
ROIC 3.69%
ROICexc 3.82%
ROICexgc 4.77%
OM 26.65%
PM (TTM) 0.89%
GM 37.81%
FCFM N/A
ROA(3y)0.24%
ROA(5y)0.32%
ROE(3y)2.5%
ROE(5y)2.99%
ROIC(3y)3.69%
ROIC(5y)3.45%
ROICexc(3y)3.83%
ROICexc(5y)3.59%
ROICexgc(3y)4.77%
ROICexgc(5y)4.39%
ROCE(3y)4.96%
ROCE(5y)4.64%
ROICexgc growth 3Y2.5%
ROICexgc growth 5Y4.8%
ROICexc growth 3Y1.58%
ROICexc growth 5Y3.93%
OM growth 3Y4.81%
OM growth 5Y5.87%
PM growth 3Y-52.22%
PM growth 5Y-32.46%
GM growth 3Y8.55%
GM growth 5Y6.54%
F-Score6
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 4.5
Debt/FCF N/A
Debt/EBITDA 6.97
Cap/Depr 213.98%
Cap/Sales 27.61%
Interest Coverage 250
Cash Conversion 33.59%
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.47
Altman-Z 0.38
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)209.51%
Cap/Depr(5y)213.66%
Cap/Sales(3y)20.38%
Cap/Sales(5y)19.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.03%
EPS 3Y-49.52%
EPS 5Y18.12%
EPS Q2Q%-56.54%
EPS Next Y-1.97%
EPS Next 2Y8.29%
EPS Next 3Y12.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.85%
Revenue growth 3Y4.33%
Revenue growth 5Y4.86%
Sales Q2Q%-21.55%
Revenue Next Year28.52%
Revenue Next 2Y35.57%
Revenue Next 3Y27.86%
Revenue Next 5YN/A
EBIT growth 1Y0.94%
EBIT growth 3Y9.35%
EBIT growth 5Y11.02%
EBIT Next Year393.96%
EBIT Next 3Y70.07%
EBIT Next 5YN/A
FCF growth 1Y-8.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.06%
OCF growth 3Y-1.38%
OCF growth 5Y3.07%